Squamous Cell Carcinoma of Head and Neck
142
34
53
43
Key Insights
Highlights
Success Rate
66% trial completion
Published Results
19 trials with published results (13%)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
15.5%
22 terminated out of 142 trials
66.2%
-20.4% vs benchmark
8%
11 trials in Phase 3/4
44%
19 of 43 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 43 completed trials
Clinical Trials (142)
Cetuximab Combined With Pembrolizumab or Finotonlimab and Chemotherapy in R/M HNSCC
A Trial Evaluating the Addition of Nivolumab to Cisplatin-RT for Treatment of Cancers of the Head and Neck
Quad Shot Versus Split Course Radiotherapy in Incurable Head and Neck Cancer
Pilot Study of Imatinib Cetuximab Combo for H & N Cancer
MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)
A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
TBio-4101 and Pembro wi/ or w/o Chemo in Recurrent/Metastatic HNSCC
Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrence
HN-BIO 02: A Phase II Randomized Study of the Effects of Delayed Elective Radiotherapy on Head and Neck MRI and Immune Response Biomarkers
Reduction in the Number of Chemotherapy Cycles in Combination With Pembrolizumab in First-line Treatment of PD-L1-positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinomas
Intraoperative Assessment of Surgical Margins Using Confocal Microscopy in Comparison With Reference Extemporaneous Examination
A Study of SI-B001+SI-B003± Chemotherapy in Patients With Locally Advanced or Metastatic Head and Neck Squamous Cell Carcinoma
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
A Study of MGC026 in Participants With Advanced Solid Tumors
A Study of DM005 in Patients With Advanced Solid Tumors
A Study of Head and Neck MRI and Tumor Microenvironment Biomarkers
Study on the Efficacy of Treatment by Radiotherapy and Pembrolizumab in Newly Diagnosed Metastatic Head & Neck Cancers
App-based Recording and Optimization of the Nutritional Status in Patients With Head and Neck Tumors During and After Radio(Chemo)Therapy